Sex: M
Vaccine: COVID19, COVID19-2
Symptoms: Cyanosis, Injection site reaction, Musculoskeletal stiffness, Tendonitis
Clinical narrative: got swelling 3 inches below his left elbow/ starting as a lump just below the patients elbow; that his left arm is very stiff; got swelling 5 to 6 inches above his elbow; pain has spread throughout the patients arm; experiencing pain in his injection site left arm; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (got swelling 3 inches below his left elbow/ starting as a lump just below the patients elbow), MUSCULOSKELETAL STIFFNESS (that his left arm is very stiff), VACCINATION SITE SWELLING (got swelling 5 to 6 inches above his elbow), PAIN IN EXTREMITY (pain has spread throughout the patients arm) and VACCINATION SITE PAIN (experiencing pain in his injection site left arm) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:The patient has , eczema, and a urinary frequency issue Medications: Ciprofloxacin Metronidazole Trazodone Symbicort Ventolin HF.  The patient's past medical history included Urinary frequency (urinary frequency issue) and Eczema. Previously administered products included for Product used for unknown indication: Influenza, CIPROFLOXACIN, VENTOLIN HFA, TRAZODONE, SYMBICORT and METRONIDAZOLE AMEL. Past adverse reactions to the above products included No adverse event with CIPROFLOXACIN, Influenza, METRONIDAZOLE AMEL, SYMBICORT, TRAZODONE and VENTOLIN HFA. Concurrent medical conditions included Asthma and COPD.    On 19-Dec-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (got swelling 3 inches below his left elbow/ starting as a lump just below the patients elbow), MUSCULOSKELETAL STIFFNESS (that his left arm is very stiff), VACCINATION SITE SWELLING (got swelling 5 to 6 inches above his elbow), PAIN IN EXTREMITY (pain has spread throughout the patients arm) and VACCINATION SITE PAIN (experiencing pain in his injection site left arm). At the time of the report, SWELLING (got swelling 3 inches below his left elbow/ starting as a lump just below the patients elbow) had not resolved and MUSCULOSKELETAL STIFFNESS (that his left arm is very stiff), VACCINATION SITE SWELLING (got swelling 5 to 6 inches above his elbow), PAIN IN EXTREMITY (pain has spread throughout the patients arm) and VACCINATION SITE PAIN (experiencing pain in his injection site left arm) outcome was unknown.            No concomitant medication was reported.  The patient received first Moderna vaccine in late January or early February 2021 lot number was unknown. The patient received the vaccine in left arm. No adverse reactions reported. The patient received the second dose of his Primary Moderna Covid-19 vaccine and did not remember when received it. The patient did not remember which arm it was received the vaccine in and the patient did not report any adverse reactions. The patient received the first booster dose in the Fall of 2021 The patient did not remember which arm received the vaccine in. No adverse reactions reported.  No treatment medication was reported.